
Madecassoside
CAS No. 34540-22-2
Madecassoside( Asiaticoside A )
Catalog No. M18455 CAS No. 34540-22-2
Madecassoside is a pentacyclic triterpene extracted from Centella asitica (L.) with anti-inflammatory, anti-oxidative and anti-aging activities.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 29 | In Stock |
![]() ![]() |
10MG | 47 | In Stock |
![]() ![]() |
25MG | 85 | In Stock |
![]() ![]() |
50MG | 146 | In Stock |
![]() ![]() |
100MG | 233 | In Stock |
![]() ![]() |
200MG | 357 | In Stock |
![]() ![]() |
500MG | 597 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameMadecassoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionMadecassoside is a pentacyclic triterpene extracted from Centella asitica (L.) with anti-inflammatory, anti-oxidative and anti-aging activities.
-
DescriptionMadecassoside is a pentacyclic triterpene extracted from Centella asitica (L.) with anti-inflammatory, anti-oxidative and anti-aging activities.
-
In VitroCell Viability Assay Cell Line:HUVECs Concentration:10, 30, 100 μmol/L Incubation Time:12 h Result:Increased cell viability to 68.9% and 78.3%, with concentration of 30 and 100 μmol/L, respectively.Western Blot Analysis Cell Line:HUVECs Concentration:10, 30, 100 μmol/L Incubation Time:12 h Result:Inhibited phosphorylation in p38 MAPK.
-
In VivoAnimal Model:Focal cerebral ischemia reperfusion injury in Sprague Dawley rats Dosage:6, 12, 24 mg/kg Administration:Intravenous injection Result:Reduced neurological deficit, infarct area, brain damage and neuronal apoptosis.Animal Model:Lipopolysaccharide-induced neurotoxicity in Sprague-Dawley rats Dosage:30-120 mg/kg for 14 days Administration:Intraperitoneal injection Result:Reduced LPS-induced cognitive impairment and imflammatory cytokine, promoted Nrf2 pathway at concentration of 120 mg/kg.
-
SynonymsAsiaticoside A
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number34540-22-2
-
Formula Weight975.12
-
Molecular FormulaC48H78O20
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 9.8 mg/mL; 10.05 mM
-
SMILES[C@@H]1([C@@H](CC[C@@]2(CC[C@@]3([C@@]4(C[C@H]([C@H]5[C@]([C@H]([C@@H](C[C@@]5([C@H]4CC=C3[C@H]12)C)O)O)(C)CO)O)C)C)C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O)O)O)O)O)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lin X, et al. Pharmacol Biochem Behav. 2014 Sep;124:434-42.
molnova catalog



related products
-
Laurolitsine
Laurolitsine is an alkaloid isolated from the leaves of Peumus boldus Molina.
-
Raddeanoside 20
Raddeanoside 20 can slightly suppress the superoxide generation induced by N-formyl-methionyl-leucyl-phenylalanine (fMLP) in a concentration dependent manner.
-
CEF14, EBV Rta Prote...
CEF14, EBV Rta Protein (28-37) is the HLA a24-restricted epitope from the epstein-barr virus Rta Protein (28-37).